Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers

Baris Sergi(Koç University), Selahattin Can Özcan(Koç University), Hamzah Syed(Koç University), Umamaheswar Duvvuri(City University of New York), Kirill Kiselyov(University of Pittsburgh), Neslihan Yuksel-Catal(Koç University)

Cell Death and Disease

August 8, 2025

10.1038/s41419-025-07900-w

Cited by 3

Related Papers

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

|Immunity|2020|688

Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

|Cancer Discovery|2013|590

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay

|Cancer|2014|502

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology

|Thyroid|2015|393

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

|Nature Communications|2021|365